Allworth Financial’s bioAffinity Technologies BIAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.37K Sell
666
-1
-0.1% -$9 ﹤0.01% 4508
2026
Q2
$8.12K Buy
+667
New +$20.4K ﹤0.01% 3844
2025
Q4
– Sell
-119
Closed -$5.3K – 5043
2025
Q3
$5.3K Hold
119
– – ﹤0.01% 3511
2025
Q2
$15.4K Buy
+119
New +$20.4K ﹤0.01% 2676

Other funds holding BIAF

Allworth Financial's BIAF Position: Q3 2026 in Review

Allworth Financial reduced its bioAffinity Technologies (BIAF) stake by 0.15% in Q3 2026, selling an estimated $9 and leaving 666 shares worth $4.37K. The position accounts for ﹤0.01% of the portfolio, ranked #4508.

Allworth Financial first reported a position in BIAF in Q2 2025 and has held it in 4 quarters since. The position peaked at $15.4K in Q2 2025. 14 funds tracked by Wall St. Rank hold BIAF as of Q3 2026.

  • Allworth Financial held 666 shares of bioAffinity Technologies worth $4.37K as of Q3 2026.
  • Allworth Financial sold 1 bioAffinity Technologies share in Q3 2026, an estimated $9.
  • bioAffinity Technologies made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #4508 holding.
  • Allworth Financial first reported a position in bioAffinity Technologies in Q2 2025 and has held it in 4 quarters since.
  • Allworth Financial's bioAffinity Technologies position peaked at $15.4K in Q2 2025.
  • 14 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.